Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Advagraf
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Advagraf 1mg modified-release capsules
0802020T0BCABAN
|
Advagraf | Tacrolimus | Malignant Disease and Immunosuppression | 2,514 |
|
Advagraf 3mg modified-release capsules
0802020T0BCADAT
|
Advagraf | Tacrolimus | Malignant Disease and Immunosuppression | 1,137 |
|
Advagraf 5mg modified-release capsules
0802020T0BCACAP
|
Advagraf | Tacrolimus | Malignant Disease and Immunosuppression | 863 |
|
Advagraf 0.5mg modified-release capsules
0802020T0BCAAAM
|
Advagraf | Tacrolimus | Malignant Disease and Immunosuppression | 570 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.